Literature DB >> 29858708

Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly.

J Scott Gabrielsen1,2, Dolores J Lamb3,4, Larry I Lipshultz5,6.   

Abstract

PURPOSE OF REVIEW: To discuss the physiologic and pathologic effects of iron on men's reproductive health. RECENT
FINDINGS: Iron overload diseases are associated with hypogonadotropic hypogonadism, infertility, and sexual dysfunction in men. Recent findings have elucidated the roles by which iron may affect the male reproductive axis. Iron is requisite for life. Iron can also catalyze the production of reactive oxygen species. To maintain balance, the human body tightly regulates dietary iron absorption. Severe iron overload disorders-e.g., hereditary hemochromatosis and β-thalassemia-occur when these regulatory mechanisms are deficient. While iron is necessary, the male reproductive system is particularly sensitive to iron overload. Hypogonadotropic hypogonadism, infertility, and sexual dysfunction commonly occur if excess iron from iron overload disorders is not removed. The average male in the USA consumes significantly more iron than needed to replace daily losses. How this degree of iron loading may affect one's reproductive health remains less clear, but there is evidence it may have adverse effects.

Entities:  

Keywords:  Anejaculation; Erectile dysfunction; Hypogonadotropic hypogonadism; Iron overload; Male infertility; Oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 29858708      PMCID: PMC6902410          DOI: 10.1007/s11934-018-0808-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  56 in total

Review 1.  Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?

Authors:  M E Sullivan; C S Thompson; M R Dashwood; M A Khan; J Y Jeremy; R J Morgan; D P Mikhailidis
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

2.  beta-thalassemia and gonadal axis: a cross-sectional, clinical study in a Greek population.

Authors:  John Papadimas; Dimitrios G Goulis; Eudokia Mandala; George Georgiadis; Vassiliki Zournatzi; Basil C Tarlatzis; John N Bontis
Journal:  Hormones (Athens)       Date:  2002 Jul-Sep       Impact factor: 2.885

3.  Pituitary iron and volume predict hypogonadism in transfusional iron overload.

Authors:  Leila J Noetzli; Ashok Panigrahy; Steven D Mittelman; Aleya Hyderi; Ani Dongelyan; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2011-12-27       Impact factor: 10.047

4.  Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes.

Authors:  T Cundy; A Bomford; J Butler; M Wheeler; R Williams
Journal:  J Clin Endocrinol Metab       Date:  1989-07       Impact factor: 5.958

5.  Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.

Authors:  Ashraf T Soliman; Ibrahim Nasr; Alaa Thabet; Mustafa M Rizk; Wael El Matary
Journal:  Metabolism       Date:  2005-01       Impact factor: 8.694

6.  Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis.

Authors:  Eric Bachman; Rui Feng; Thomas Travison; Michelle Li; Gordana Olbina; Vaughn Ostland; Jagadish Ulloor; Anqi Zhang; Shehzad Basaria; Tomas Ganz; Mark Westerman; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

7.  Hypogonadism in hemochromatosis: reversal with iron depletion.

Authors:  T M Kelly; C Q Edwards; A W Meikle; J P Kushner
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

8.  Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study.

Authors:  C Bergeron; K Kovacs
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

Review 9.  Ironing out Ferroportin.

Authors:  Hal Drakesmith; Elizabeta Nemeth; Tomas Ganz
Journal:  Cell Metab       Date:  2015-10-01       Impact factor: 27.287

10.  Redox regulation of tyrosine phosphorylation in human spermatozoa and its role in the control of human sperm function.

Authors:  R J Aitken; M Paterson; H Fisher; D W Buckingham; M van Duin
Journal:  J Cell Sci       Date:  1995-05       Impact factor: 5.285

View more
  3 in total

1.  Penile implant surgery for conservative therapy resistant erectile dysfunction in a 19y-old.

Authors:  Filip Weckx; Koenraad Van Renterghem
Journal:  Urol Case Rep       Date:  2020-04-04

2.  Safety of iron hydroxide adipate tartrate as a novel food pursuant to Regulation (EU) 2015/2283 and as a source of iron in the context of Directive 2002/46/EC.

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Miguel Prieto Maradona; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Josef Rudolf Schlatter; Henk van Loveren; Andrea Germini; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2021-12-10

Review 3.  New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.

Authors:  Mara Carsote; Cristina Vasiliu; Alexandra Ioana Trandafir; Simona Elena Albu; Mihai-Cristian Dumitrascu; Adelina Popa; Claudia Mehedintu; Razvan-Cosmin Petca; Aida Petca; Florica Sandru
Journal:  Diagnostics (Basel)       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.